Freeline Therapeutics, a company with the ambition of transforming the lives of patients suffering from inherited systemic debilitating diseases, announced the pricing of its initial public offering in the United States. Freeline Nasdaq IPO is UCL Technology Fund's 3rd IPO since its inception in 2016.
Quantexa, AlbionVC portfolio company named among the 15 leading European AI start-ups by the Business Insider. Quantexa uses artificial intelligence and big data to help banks and other major institutions to detect fraud. To date the company has raised $23.3 million.
Aridhia, an AlbionVC portfolio company has set up International Covid-19 Data Research Alliance and Workbench to unite leading life science, philanthropic and research organisations to respond to the global pandeminic.
Locum's Nest technology connects short-staffed hospital departments and GP practices with thousands of clinicians a service they have made free to access in response to the Covid-19 virus
AstronauTx Ltd is a biotech company developing new medicines for the treatment of Alzheimer’s disease and other neurodegenerative diseases, announces £1 million investment from the UCL Technology Fund.